Interindividual Variability of Apixaban Plasma Concentrations: Influence of Clinical and Genetic Factors in a Real-Life Cohort of Atrial Fibrillation Patients
(1) Background: Prescribing apixaban for stroke prevention has significantly increased in patients with non-valvular atrial fibrillation (NVAF). The <i>ABCB<sub>1</sub></i> genotype can influence apixaban absorption and bioavailability. The aim of the present study was to ass...
Main Authors: | Adela-Nicoleta Roşian, Ştefan Horia Roşian, Bela Kiss, Maria Georgia Ştefan, Adrian Pavel Trifa, Camelia Diana Ober, Ovidiu Anchidin, Anca Dana Buzoianu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/4/438 |
Similar Items
-
An Exploratory Association Analysis of <i>ABCB</i><sub>1</sub> rs1045642 and <i>ABCB</i><sub>1</sub> rs4148738 with Non-Major Bleeding Risk in Atrial Fibrillation Patients Treated with Dabigatran or Apixaban
by: Adela-Nicoleta Roşian, et al.
Published: (2020-09-01) -
Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis
by: L. V. Fedina, et al.
Published: (2023-01-01) -
Design and evaluation of oral formulation for apixaban
by: Chien-Chiao Wang, et al.
Published: (2023-08-01) -
Traumatic Pseudoaneursym of Superficial Temporal Artery in an Octogenarian Patient Under Apixaban Therapy
by: Sertan Özyalçın, et al.
Published: (2020-02-01) -
Análisis coste-utilidad de apixabán frente al ácido acetilsalicílico en la prevención del ictus en pacientes con fibrilación auricular no valvular en España
by: Ginés Escolar-Albaladejo, et al.
Published: (2016-06-01)